Product Categories
| Country: | United States |
|---|---|
| Tel: | +1-781-999-5354 |
| Mobile: | +1-00000000000 |
| E-mail: | marketing@targetmol.com |
| QQ: | |
| Skype: | Chat Now! |
| Address: | 36?Washington?Street, Wellesley?Hills |
|
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
|
|
| Product Name | MF | CAS | Details |
|---|
| Amrinone | C10H9N3O | 60719-84-8 | Details |
| (Rac)-5-Keto Fluvastatin | C24H24FNO4 | 1160169-39-0 | Details |
| Ibafloxacine；R835;S25930 | C15H14FNO3 | 91618-36-9 | Details |
| Rabdosiin | C36H30O16 | 263397-69-9 | Details |
| (R)-Nicardipine；(R)-YC-93 free base | C26H29N3O6 | 76093-35-1 | Details |
| (R)-Plevitrexed；(R)-ZD 9331;(R)-BGC9331 | C26H25FN8O4 | 153537-74-7 | Details |
| Plevitrexed；BGC9331;ZD 9331 | C26H25FN8O4 | 153537-73-6 | Details |
| (R)-(+)-Anatabine | C10H12N2 | 126454-22-6 | Details |
| (R)-(+)-HA-966；(+)-HA-966 | C4H8N2O2 | 123931-04-4 | Details |
| (R)-Praziquantel-d11；(R)-Praziquantel D11 | C19H24N2O2 | 1399880-38-6 | Details |
| (R)-PS210 | C19H15F3O5 | 1410101-89-1 | Details |
| (R,R)-Glycopyrrolate；(R,R)-Glycopyrrolate bromide;(R,R)-Glycopyrronium bromide | C19H28NO3.Br | 475468-09-8 | Details |
| Ciprofibrate | C13H14Cl2O3 | 52214-84-3 | Details |
| Levonorgestrel | C21H28O2 | 797-63-7 | Details |
| (R)-(-)-α-Methylhistamine dihydrobromide | C6H12BrN3 | 868698-49-1 | Details |
| (S)-Thalidomide | C13H10N2O4 | 841-67-8 | Details |
| (R)-SCH 42495 | C20H29NO4S2 | 156792-25-5 | Details |
| (R)-Thalidomide；(R)-(+)-Thalidomide | C13H10N2O4 | 2614-06-4 | Details |
| (R)-Trolox | C14H18O4 | 53101-49-8 | Details |
| (R)-Verapamil hydrochloride；(R)-(+)-Verapamil hydrochloride | C27H41ClN2O5 | 38176-02-2 | Details |
| RIG-1 modulator 1 | C14H17N5OS2 | 1428729-63-8 | Details |
| RIP1 kinase inhibitor 1 | C24H20ClN5O3 | 2095515-38-9 | Details |
| (±)-Darifenacin；(±)-UK-88525 | C28H30N2O2 | 133033-93-9 | Details |
| (±)?-?Vasicine；(±)?-Peganine | C11H12N2O | 6159-56-4 | Details |
| Ramelteon metabolite M-II | C16H21NO3 | 896736-21-3 | Details |
| Raloxifene 6-glucuronide | C34H35NO10S | 174264-50-7 | Details |
| Raloxifene 6,4'-Bis-β-D-glucuronide | C40H43NO16S | 182507-20-6 | Details |
| Raloxifene 4'-glucuronide | C34H35NO10S | 182507-22-8 | Details |
| Radafaxine hydrochloride；BW-306U;GW-353162A | C13H19Cl2NO2 | 106083-71-0 | Details |
| Radioprotectin-1 | C23H19ClN2O6S | 1622006-09-0 | Details |
| RAS GTPase inhibitor 1 | C27H28ClF4N5O2 | 2252242-32-1 | Details |
| Razaxaban hydrochloride；DPC 906 hydrochloride;BMS 561389 hydrochloride | C24H21ClF4N8O2 | 405940-76-3 | Details |
| RD3-0028 | C8H8S2 | 3886-39-3 | Details |
| Refametinib R enantiomer | C19H20F3IN2O5S | 923032-38-6 | Details |
| Tripelennamine hydrochloride；Tripelennamine HCl;Pyribenzamine hydrochloride;Pyribenzamine HCl | C16H22ClN3 | 154-69-8 | Details |
| RG7834 | C22H27NO6 | 2072057-17-9 | Details |
| RG7800 | C24H28N6O | 1449598-06-4 | Details |
| Cytarabine | C9H13N3O5 | 147-94-4 | Details |
| Basimglurant | C18H13ClFN3 | 802906-73-6 | Details |
| Reverse transcriptase-IN-1 | C25H17N7O2 | 2380001-43-2 | Details |
| Reutericyclin；Reutericycline | C20H31NO4 | 303957-69-9 | Details |
| REV7/REV3L-IN-1 | C19H21N3O3S | 1979192-13-6 | Details |
| Reversan；CBLC4H10 | C26H27N5O2 | 313397-13-6 | Details |
| Retro-2 cycl | C19H16N2OS | 1429192-00-6 | Details |
| Rho-Kinase-IN-1 | C20H24N4S | 1035094-83-7 | Details |
| (Rac)-VU 6008667 | C24H17ClF2N2O2 | 2092917-63-8 | Details |
| (Rac)-SEP-363856；(Rac)-SEP-856 | C9H13NOS | 1310426-29-9 | Details |
| (Rac)-Rotigotine hydrochloride | C19H26ClNOS | 102120-99-0 | Details |
| (Rac)-Telmesteine | C7H11NO4S | 127657-29-8 | Details |
| (Rac)-Plevitrexed；(Rac)-BGC9331;(Rac)-ZD 9331 | C26H25FN8O4 | 153538-08-0 | Details |
| (Rac)-PT2399 | C17H10F5NO4S | 1672662-07-5 | Details |
| PF-06250112 | C22H20F2N6O2 | 1609465-89-5 | Details |
| (Rac)-MGV354 | C35H37N5O3 | 1852495-86-3 | Details |
| Abacavir | C14H18N6O | 136470-78-5 | Details |
| (Rac)-Mirabegron-d5；(Rac)-YM178 D5;(Rac)-Mirabegron D5 | C21H19D5N4O2S | 1215807-38-7 | Details |
| (Rac)-LM11A-31 dihydrochloride | C12H26ClN3O2 | 1214672-15-7 | Details |
| (Rac)-BRD0705 | C20H23N3O | 1597440-03-3 | Details |
| BAY1238097 | C25H33N5O3 | 1564268-08-1 | Details |
| (Rac)-E1R | C13H16N2O2 | 787623-60-3 | Details |
| (Rac)-BI 703704 | C32H37N3O4S | 1423067-48-4 | Details |
| Terfenadine | C32H41NO2 | 50679-08-8 | Details |
| (Rac)-Apremilast D5；(Rac)-CC-10004 D5 | C22H24N2O7S | 1258597-61-3 | Details |
| (Rac)-AMG8379 | C25H16ClF2N3O5S | 1641574-26-6 | Details |
| (Rac)-BAY-985 | C27H30F3N9O | 2101925-20-4 | Details |
| (Rac)-AZD 6482；(Rac)-KIN-193 | C22H24N4O4 | 663620-70-0 | Details |
| (Rac)-Acolbifene | C29H31NO4 | 151533-34-5 | Details |
| (Rac)-ABT-202 dihydrochloride | C9H14ClN3 | 1258641-38-1 | Details |
| (Rac)-BAY1238097 | C25H33N5O3 | 1564268-19-4 | Details |
| (R)-Terazosin | C19H25N5O4 | 109351-34-0 | Details |
| (R)-Simurosertib | C17H19N5OS | 1330782-69-8 | Details |
| Vincristine sulfate | C46H58N4O14S | 2068-78-2 | Details |
| Regorafenib-d3；BAY 73-4506 D3;Regorafenib D3 | C21H12ClD3F4N4O3 | 1255386-16-3 | Details |
| rel-α-Vitamin E；rel-D-α-Tocopherol;rel-(+)-α-Tocopherol | C29H50O2 | 2074-53-5 | Details |
| (rel)-AR234960 | C27H30FN5O5S | 1408311-94-3 | Details |
| (rel)-Tranylcypromine D5 hydrochloride；2-Phenylcyclopropylamine D5 hydrochloride | C9H7D5ClN | 107077-98-5 | Details |
| ReN-1869 hydrochloride；NNC-05-1869 hydrochloride | C24H28ClNO2 | 170149-76-5 | Details |
| Rentiapril；SA-446 | C13H15NO4S2 | 80830-42-8 | Details |
| Reslizumab；Sch 55700 | 241473-69-8 | Details |
| Resveratrol analog 1 | C14H11FO2 | 861446-16-4 | Details |
| Retagliptin Phosphate | C19H18F6N4O3 | 1256756-88-3 | Details |
| Emzadirib | C27H40N4O6S2 | 2301085-04-9 | Details |
| Retaspimycin | C31H45N3O8 | 857402-23-4 | Details |
| Resolvin D2；RvD2 | C22H32O5 | 810668-37-2 | Details |
| (Rac)-IDO1-IN-5 | C23H25FN2O3 | 2166616-74-4 | Details |
| PT2399 | C17H10F5NO4S | 1672662-14-4 | Details |
| Prinoxodan；RGW2938 | C13H14N4O2 | 111786-07-3 | Details |
| Ribocil-C | C21H21N7OS | 1825355-56-3 | Details |
| Reparixin L-lysine salt | C20H35N3O5S | 266359-93-7 | Details |
| RG-12915 | C20H25ClN2O2 | 136174-04-4 | Details |
| Rasagiline 13C3 mesylate racemic；TVP1012 13C3 racemic;AGN1135 13C3 racemic | C13H17NO3S | 1216757-55-9 | Details |
| Rapamycin-d3；AY-22989-d3;Sirolimus-d3 | C51H76D3NO13 | 392711-19-2 | Details |
| Rapacuronium bromide；Org 9487 | C37H61BrN2O4 | 156137-99-4 | Details |
| Dixanthogen | C6H10O2S4 | 502-55-6 | Details |
| (S)-Mirtazapine | C17H19N3 | 61337-87-9 | Details |
| (R)-Mirtazapine | C17H19N3 | 61364-37-2 | Details |
| R916562 | C26H30ClN9S | 1037798-41-6 | Details |
| Resveratrol analog 2 | C16H13FO3 | 915378-82-4 | Details |
| RBN-2397 | C20H23F6N7O3 | 2381037-82-5 | Details |
| RAF mutant-IN-1 | C23H17Cl2FN6O2S | 2340020-82-6 | Details |
| (R)-VU 6008667 | C24H17ClF2N2O2 | 2097818-14-7 | Details |
| Product Total： Product Page： | ||||
| 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 | ||||